NClip

Stimulant Use Disorders

4 min read

Stimulant Use Disorders

Key Points

  • Stimulants increase dopamine signaling, reinforcing repeated use and rapid addiction cycling.
  • Commonly misused stimulants include prescription amphetamines, methamphetamine, cocaine/crack, and MDMA.
  • Binge patterns are common because stimulant highs start and fade quickly.
  • Withdrawal is usually not medically lethal but may include severe depression and suicidal ideation.

Pathophysiology

Stimulants amplify reward signaling through dopamine pathways, then drive neuroadaptation that reduces sensitivity to usual doses. The result is escalating dose/frequency, compulsive seeking, and intensified crash symptoms during abstinence.

Chronic exposure disrupts sleep, appetite, cognition, and impulse control. Both intoxication and withdrawal can produce paranoia, hallucinations, and high-risk behavior, creating major safety concerns in acute and outpatient settings.

Classification

  • Prescription stimulant misuse: Nonmedical use of medications such as methylphenidate or amphetamine salts.
  • Illicit stimulant use: Methamphetamine, cocaine, crack, and related street drugs.
  • Synthetic club-drug stimulant use: MDMA-related misuse with temperature and cardiovascular risk.

Nursing Assessment

NCLEX Focus

Prioritize cardiopulmonary and neuropsychiatric stability in intoxication, then monitor crash-phase mood risk during withdrawal.

  • Assess substance type, route (smoked, snorted, oral, injected), frequency, and binge pattern.
  • Assess signs of intoxication: tachycardia, hypertension, agitation, chest pain, hyperthermia, and paranoia.
  • Assess behavior-change intoxication cues such as euphoria or blunted affect, altered sociability, hypervigilance, tension/anger, and impaired judgment.
  • Assess expanded intoxication risk cues: pupillary dilation, diaphoresis/chills, nausea-vomiting, dyskinesia/dystonia, and seizure or coma in severe toxicity.
  • Assess psychosis risk (hallucinations, persecutory ideation) and violent behavior risk.
  • Assess withdrawal signs: depressed mood, lethargy, insomnia, severe craving, suicidality.
  • Assess withdrawal phase pattern over time: early sadness/anxiety/craving, followed by fatigue-exhaustion and insomnia/depression, with possible intensified craving waves that can persist for days to weeks.
  • Distinguish withdrawal patterns by stimulant type when possible (for example cocaine: depression, fatigue, increased appetite, vivid unpleasant dreams; methamphetamine: depression, anxiety, fatigue).
  • Assess methamphetamine-specific chronic-harm cues such as severe dental decay, skin-picking lesions, marked weight loss, memory decline, and escalating violence risk.
  • In adolescents and college-age clients, assess nonmedical prescription-stimulant use motives (for example academic performance pressure) and nonprescribed acquisition pathways.
  • Assess pregnancy status because stimulant exposure in pregnancy increases risks such as preterm delivery, low birth weight, and placental complications.
  • Assess polysubstance use, especially concurrent alcohol use that increases cardiac toxicity risk.

Nursing Interventions

  • Ensure a low-stimulation, safety-focused environment during acute intoxication and agitation.
  • Monitor cardiovascular status, temperature, hydration, and neurologic changes closely.
  • For severe intoxication, prioritize rapid chemical sedation and aggressive cooling (hyperthermia management); antipyretics are not effective for exertional/hypermetabolic hyperthermia patterns.
  • Avoid routine physical-restraint escalation when possible in severe stimulant agitation because prolonged struggling can worsen acidosis, hyperthermia, and cardiac-collapse risk.
  • Coordinate symptom-focused treatment and psychiatric evaluation when indicated.
  • Escalate early for ICU-level complications (arrhythmia, myocardial injury, seizures, rhabdomyolysis, acute kidney injury, or multi-organ failure).
  • Begin relapse-prevention counseling, trigger identification, and coping-skills teaching.
  • Link clients to structured therapy, group support, and step-down recovery resources.

Mood-Crash Safety Risk

Early stimulant withdrawal can include severe depression and suicidal ideation; maintain active safety monitoring.

Pharmacology

No single reversal agent exists for stimulant overdose comparable to naloxone for opioids. Acute management is symptom-directed, including medications for severe cardiovascular or agitation-related complications per protocol.

Long-term treatment emphasizes behavioral therapies, recovery support, and management of co-occurring psychiatric disorders. Nurses monitor adherence, sleep restoration, nutrition recovery, and relapse-warning patterns.

Clinical Judgment Application

Clinical Scenario

A client presents after several days of stimulant binge use with insomnia, paranoia, tachycardia, and chest discomfort.

  • Recognize Cues: Extended binge, autonomic activation, psychotic symptoms, and exhaustion.
  • Analyze Cues: High-risk stimulant intoxication with potential cardiac and psychiatric complications.
  • Prioritize Hypotheses: Stabilize cardiopulmonary status and prevent harm.
  • Generate Solutions: Start close monitoring, symptom-directed treatment, and environmental de-escalation.
  • Take Action: Implement safety precautions and coordinate urgent interprofessional management.
  • Evaluate Outcomes: Confirm physiologic stabilization and transition to withdrawal/recovery planning.

Graph View